ATE370124T1 - Inhibitoren dernicht-nukleosid-inhibitoren der reversen transkriptase - Google Patents
Inhibitoren dernicht-nukleosid-inhibitoren der reversen transkriptaseInfo
- Publication number
- ATE370124T1 ATE370124T1 AT04711607T AT04711607T ATE370124T1 AT E370124 T1 ATE370124 T1 AT E370124T1 AT 04711607 T AT04711607 T AT 04711607T AT 04711607 T AT04711607 T AT 04711607T AT E370124 T1 ATE370124 T1 AT E370124T1
- Authority
- AT
- Austria
- Prior art keywords
- reverse transcriptase
- nucleoside inhibitors
- nucleoside
- inhibitors
- transcriptase
- Prior art date
Links
- 102100034343 Integrase Human genes 0.000 title 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000002777 nucleoside Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44797403P | 2003-02-18 | 2003-02-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE370124T1 true ATE370124T1 (de) | 2007-09-15 |
Family
ID=32908518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04711607T ATE370124T1 (de) | 2003-02-18 | 2004-02-17 | Inhibitoren dernicht-nukleosid-inhibitoren der reversen transkriptase |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7241794B2 (enExample) |
| EP (1) | EP1597235B1 (enExample) |
| JP (1) | JP4608480B2 (enExample) |
| KR (1) | KR100776093B1 (enExample) |
| CN (1) | CN100389109C (enExample) |
| AR (1) | AR043195A1 (enExample) |
| AT (1) | ATE370124T1 (enExample) |
| BR (1) | BRPI0407591A (enExample) |
| CA (1) | CA2515151C (enExample) |
| CL (1) | CL2004000270A1 (enExample) |
| DE (1) | DE602004008227T2 (enExample) |
| ES (1) | ES2291854T3 (enExample) |
| MX (1) | MXPA05008748A (enExample) |
| PL (1) | PL378556A1 (enExample) |
| RU (1) | RU2305680C2 (enExample) |
| TW (1) | TW200423930A (enExample) |
| WO (1) | WO2004074257A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004099157A1 (en) * | 2003-05-07 | 2004-11-18 | Pfizer Products Inc. | Cannabinoid receptor ligands and uses thereof |
| RU2383536C2 (ru) | 2004-08-04 | 2010-03-10 | Тайсо Фармасьютикал Ко., Лтд. | Производное триазола |
| UA87884C2 (uk) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
| EP1988083B1 (en) | 2006-02-03 | 2014-04-02 | Taisho Pharmaceutical Co., Ltd. | Triazole derivative |
| US7994204B2 (en) | 2006-02-06 | 2011-08-09 | Taisho Pharmaceutical Co., Ltd | Binding inhibitor of sphingosine-1-phosphate |
| ES2381695T3 (es) * | 2006-02-14 | 2012-05-30 | Ihara Chemical Industry Co., Ltd. | Procedimiento para producir un compuesto 5-alcoxi-4-hidroximetilpirazol |
| CL2007002105A1 (es) * | 2006-07-21 | 2008-02-22 | Hoffmann La Roche | Compuestos derivados de 2-[3-(3-cianofenoxi)(fenoxi o fenilsulfanil)]-n-fenil acetamida, inhibidores de la transcriptasa inversa del vih; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar u |
| AU2007286345B2 (en) | 2006-08-16 | 2012-03-08 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
| CA2682637A1 (en) * | 2007-03-29 | 2008-10-09 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
| SI2177512T1 (sl) | 2007-08-01 | 2012-06-29 | Taisho Pharmaceutical Co Ltd | Inhibitor vezave S1P1 |
| JP5411160B2 (ja) * | 2007-12-21 | 2014-02-12 | エフ．ホフマン−ラ ロシュ アーゲー | 複素環式抗ウイルス性化合物 |
| DE102008015033A1 (de) * | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| MA34170B1 (fr) | 2010-03-30 | 2013-04-03 | Merck Canada Inc | Inhibiteurs de transcriptase inverse non nucléosidiques |
| JP5722891B2 (ja) | 2010-07-15 | 2015-05-27 | 大日本住友製薬株式会社 | ピラゾール化合物 |
| EP2508511A1 (en) | 2011-04-07 | 2012-10-10 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| EP2822931B1 (en) | 2012-03-09 | 2017-05-03 | Inception 2, Inc. | Triazolone compounds and uses thereof |
| KR20150023822A (ko) | 2012-06-20 | 2015-03-05 | 벤더르빌트 유니버시티 | Mglur5 수용체의 알로스테릭 조절물질로서 치환된 바이사이클릭 알콕시 피라졸 유사체 |
| WO2013192346A1 (en) | 2012-06-20 | 2013-12-27 | Vanderbilt University | Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mglur5 receptors |
| JO3470B1 (ar) | 2012-10-08 | 2020-07-05 | Merck Sharp & Dohme | مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv |
| JP6404230B2 (ja) | 2012-12-20 | 2018-10-10 | インセプション ２、 インコーポレイテッド | トリアゾロン化合物およびその使用 |
| CA2921420A1 (en) | 2013-09-06 | 2015-03-12 | Inception 2, Inc. | Triazolone compounds and uses thereof |
| CN106456639B (zh) | 2014-04-01 | 2019-05-10 | 默沙东公司 | Hiv逆转录酶抑制剂的前药 |
| AU2015317823A1 (en) | 2014-09-17 | 2017-03-23 | Ironwood Pharmaceuticals, Inc. | sGC stimulators |
| WO2016044445A2 (en) | 2014-09-17 | 2016-03-24 | Ironwood Pharmaceuticals, Inc. | sGC STIMULATORS |
| EP3271336A1 (en) * | 2015-03-19 | 2018-01-24 | E. I. du Pont de Nemours and Company | Fungicidal pyrazoles |
| EP3478665A1 (en) * | 2016-06-29 | 2019-05-08 | Esteve Pharmaceuticals, S.A. | Pyrazole derivatives having activity against pain |
| CN110818636A (zh) * | 2019-11-29 | 2020-02-21 | 河北科技大学 | 一种化合物或其盐及其应用和合成方法 |
| CN115677585B (zh) * | 2022-10-31 | 2024-03-19 | 上海群力化工有限公司 | 一种甲醛吡唑衍生物的合成工艺 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0786455B1 (en) | 1994-09-26 | 2003-12-03 | Shionogi & Co., Ltd. | Imidazole derivative |
| DE19734664A1 (de) * | 1997-08-11 | 1999-02-18 | Bayer Ag | (Hetero)Aryloxypyrazole |
| GB0016787D0 (en) * | 2000-07-07 | 2000-08-30 | Pfizer Ltd | Compounds useful in therapy |
| US20030008841A1 (en) * | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
| GB0024795D0 (en) * | 2000-10-10 | 2000-11-22 | Hoffmann La Roche | Pyrazole derivatives for the treatment of viral diseases |
| GB0028484D0 (en) * | 2000-11-22 | 2001-01-10 | Hoffmann La Roche | Imidazolone derivatives for the treatment of viral diseases |
| EE05400B1 (et) * | 2001-04-10 | 2011-04-15 | Pfizer Inc. | Prasoolderivaadid, neid v?i nende farmatseutiliselt vastuv?etavaid sooli, solvaate v?i derivaate sisaldavad farmatseutilised kompositsioonid, nende kasutamine ning meetodid nende valmistamiseks |
| GB0113524D0 (en) * | 2001-06-04 | 2001-07-25 | Hoffmann La Roche | Pyrazole derivatives |
-
2004
- 2004-02-12 TW TW093103358A patent/TW200423930A/zh unknown
- 2004-02-16 CL CL200400270A patent/CL2004000270A1/es unknown
- 2004-02-17 EP EP04711607A patent/EP1597235B1/en not_active Expired - Lifetime
- 2004-02-17 MX MXPA05008748A patent/MXPA05008748A/es active IP Right Grant
- 2004-02-17 ES ES04711607T patent/ES2291854T3/es not_active Expired - Lifetime
- 2004-02-17 WO PCT/EP2004/001477 patent/WO2004074257A1/en not_active Ceased
- 2004-02-17 KR KR1020057015085A patent/KR100776093B1/ko not_active Expired - Fee Related
- 2004-02-17 RU RU2005128832/04A patent/RU2305680C2/ru active
- 2004-02-17 CA CA2515151A patent/CA2515151C/en not_active Expired - Fee Related
- 2004-02-17 AT AT04711607T patent/ATE370124T1/de not_active IP Right Cessation
- 2004-02-17 DE DE602004008227T patent/DE602004008227T2/de not_active Expired - Lifetime
- 2004-02-17 BR BRPI0407591-9A patent/BRPI0407591A/pt not_active IP Right Cessation
- 2004-02-17 AR ARP040100477A patent/AR043195A1/es not_active Application Discontinuation
- 2004-02-17 JP JP2006500034A patent/JP4608480B2/ja not_active Expired - Fee Related
- 2004-02-17 PL PL378556A patent/PL378556A1/pl not_active Application Discontinuation
- 2004-02-17 CN CNB2004800044061A patent/CN100389109C/zh not_active Expired - Fee Related
- 2004-02-18 US US10/781,373 patent/US7241794B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CL2004000270A1 (es) | 2005-02-04 |
| PL378556A1 (pl) | 2006-05-02 |
| EP1597235B1 (en) | 2007-08-15 |
| JP4608480B2 (ja) | 2011-01-12 |
| EP1597235A1 (en) | 2005-11-23 |
| KR100776093B1 (ko) | 2007-11-15 |
| WO2004074257A1 (en) | 2004-09-02 |
| ES2291854T3 (es) | 2008-03-01 |
| CN100389109C (zh) | 2008-05-21 |
| JP2006515339A (ja) | 2006-05-25 |
| US20040192666A1 (en) | 2004-09-30 |
| AU2004213134A1 (en) | 2004-09-02 |
| DE602004008227D1 (de) | 2007-09-27 |
| BRPI0407591A (pt) | 2006-02-14 |
| TW200423930A (en) | 2004-11-16 |
| DE602004008227T2 (de) | 2008-05-15 |
| CA2515151C (en) | 2010-11-30 |
| RU2305680C2 (ru) | 2007-09-10 |
| AR043195A1 (es) | 2005-07-20 |
| KR20050105471A (ko) | 2005-11-04 |
| MXPA05008748A (es) | 2005-09-20 |
| RU2005128832A (ru) | 2006-04-27 |
| US7241794B2 (en) | 2007-07-10 |
| CA2515151A1 (en) | 2004-09-02 |
| CN1751028A (zh) | 2006-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE370124T1 (de) | Inhibitoren dernicht-nukleosid-inhibitoren der reversen transkriptase | |
| NO20161397A1 (no) | Ikke-nukleosidbaserte revers-transkriptase-inhibitorer | |
| DK1562589T3 (da) | Diaminotriazoler der er nyttige som inhibitorer af proteinkinaser | |
| LTPA2017004I1 (lt) | Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai | |
| CY2014011I1 (el) | Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης | |
| DK1532145T3 (da) | Pyrazolpræparater der er anvendelige som inhibitorer af GSK-3 | |
| SE0701538L (sv) | Azaspiroalkanderivat som hämmare av metalloproteaser | |
| CY2013042I2 (el) | Αναστολεις πυριδυλιου της σηματοδοτησης hedgehog | |
| ATE425138T1 (de) | N-phenyl-phenylacetamid-nichtnukleosidinhibitor n reverser transkriptase | |
| EP1788874A4 (en) | 5-AZACYTIDINE SALTS | |
| ATE459624T1 (de) | Inhibitoren der reversen transkriptase des hiv | |
| DE602005019971D1 (de) | Inhibitoren von cysteinprotease | |
| NO20054264D0 (no) | Ikke-Nukleoside Revers Transkriptase-Inhibitorer I for behandling av HIV-medierte sydommer | |
| BRPI0715193A2 (pt) | inibidores nço-nucleosÍdicos da transcriptase reversa | |
| DE60324418D1 (de) | Nicht-nukleosidische inhibitoren der reversen transkriptase | |
| EP1660436A4 (en) | cathepsin inhibitors | |
| DK1786799T3 (da) | Hidtil ukendte phenylaminopyrimidinderivater som inhibitorer af bcr-abl-kinase | |
| DK1763517T3 (da) | Pyrimidinderivater som 11beta-HSD1-inhibitorer | |
| ATE322492T1 (de) | Nicht-nukleosid reverse transkriptase inhibitoren | |
| DK1799707T3 (da) | Rekombineret Kunitztypeinhibitor | |
| EP1899340A4 (en) | NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS | |
| IS7963A (is) | Efnasambönd með hamlandi virkni gegn prólýlólígópeptíðasa | |
| DE60326035D1 (de) | Dipyridodiazepinone als inhibitoren der reversen transkriptase | |
| DK1373267T3 (da) | Non-nucleoside revers transkriptase-inhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1597235 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |